OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The kynurenine pathway in treatment-resistant schizophrenia at the crossroads between pathophysiology and pharmacotherapy
Jacopo Sapienza, Giulia Agostoni, Stefano Dall’Acqua, et al.
Schizophrenia Research (2023) Vol. 264, pp. 71-80
Closed Access | Times Cited: 14
Jacopo Sapienza, Giulia Agostoni, Stefano Dall’Acqua, et al.
Schizophrenia Research (2023) Vol. 264, pp. 71-80
Closed Access | Times Cited: 14
Showing 14 citing articles:
Neuroactive Kynurenines as Pharmacological Targets: New Experimental Tools and Exciting Therapeutic Opportunities
Ana Pocivavsek, Robert Schwarcz, Sophie Erhardt
Pharmacological Reviews (2024) Vol. 76, Iss. 6, pp. 978-1008
Closed Access | Times Cited: 8
Ana Pocivavsek, Robert Schwarcz, Sophie Erhardt
Pharmacological Reviews (2024) Vol. 76, Iss. 6, pp. 978-1008
Closed Access | Times Cited: 8
Therapeutic modulation of the kynurenine pathway in severe mental illness and comorbidities: A potential role for serotonergic psychedelics
Antonella Campanale, Antonio Inserra, Stefano Comai
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 134, pp. 111058-111058
Open Access | Times Cited: 6
Antonella Campanale, Antonio Inserra, Stefano Comai
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 134, pp. 111058-111058
Open Access | Times Cited: 6
Neuroinflammation and kynurenines in schizophrenia: Impact on cognition depending on cognitive functioning and modulatory properties in relation to cognitive remediation and aerobic exercise
Jacopo Sapienza, Giulia Agostoni, Stefano Comai, et al.
Schizophrenia Research Cognition (2024) Vol. 38, pp. 100328-100328
Open Access | Times Cited: 6
Jacopo Sapienza, Giulia Agostoni, Stefano Comai, et al.
Schizophrenia Research Cognition (2024) Vol. 38, pp. 100328-100328
Open Access | Times Cited: 6
Elevated serum kynurenic acid in individuals with first-episode psychosis and insufficient response to antipsychotics
Alexandros Hatzimanolis, Stefania Foteli, Lida‐Alkisti Xenaki, et al.
Schizophrenia (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Alexandros Hatzimanolis, Stefania Foteli, Lida‐Alkisti Xenaki, et al.
Schizophrenia (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Applied pharmacogenetics to predict response to treatment of first psychotic episode: study protocol
Sergi Mas, Laura Julià, Manuel J. Cuesta, et al.
Frontiers in Psychiatry (2025) Vol. 15
Open Access
Sergi Mas, Laura Julià, Manuel J. Cuesta, et al.
Frontiers in Psychiatry (2025) Vol. 15
Open Access
Potential role for kynurenine pathway in increased COVID-19 mortality of patients with schizophrenia
Pengli Wang, Zhen-Ying Li, Jie Wang, et al.
Journal of Psychiatric Research (2025) Vol. 183, pp. 289-295
Closed Access
Pengli Wang, Zhen-Ying Li, Jie Wang, et al.
Journal of Psychiatric Research (2025) Vol. 183, pp. 289-295
Closed Access
Metabolic Syndrome and Schizophrenia: Adding a Piece to the Interplay Between the Kynurenine Pathway and Inflammation
Jacopo Sapienza, Giulia Agostoni, Federica Repaci, et al.
Metabolites (2025) Vol. 15, Iss. 3, pp. 176-176
Open Access
Jacopo Sapienza, Giulia Agostoni, Federica Repaci, et al.
Metabolites (2025) Vol. 15, Iss. 3, pp. 176-176
Open Access
Developing a risk assessment model for treatment-resistant schizophrenia: The role of niacin receptor GPR109A and prostaglandin receptors DP1, EP2, and EP4 in the niacin-induced flushing pathway
Chi-Wei Chiu, Bao-Yu Chen, Jin-Jia Lin, et al.
Schizophrenia Research (2025) Vol. 280, pp. 30-38
Closed Access
Chi-Wei Chiu, Bao-Yu Chen, Jin-Jia Lin, et al.
Schizophrenia Research (2025) Vol. 280, pp. 30-38
Closed Access
Psychedelics and schizophrenia: a double-edged sword
Jacopo Sapienza, Francesca Martini, Stefano Comai, et al.
Molecular Psychiatry (2024)
Closed Access | Times Cited: 3
Jacopo Sapienza, Francesca Martini, Stefano Comai, et al.
Molecular Psychiatry (2024)
Closed Access | Times Cited: 3
Kynurenic acid inflammatory signaling expands in primates and impairs prefrontal cortical cognition
Shengtao Yang, Dibyadeep Datta, Fenna M. Krienen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Shengtao Yang, Dibyadeep Datta, Fenna M. Krienen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
The clock is ticking on schizophrenia: a study protocol for a translational study integrating phenotypic, genomic, microbiome and biomolecular data to overcome disability
Giacomo Mercuriali, Lorenzo Lodde, Pasquale Paribello, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 1
Giacomo Mercuriali, Lorenzo Lodde, Pasquale Paribello, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 1
Brain metabolic profiling of schizophrenia: a path towards a better understanding of the neuropathogenesis of psychosis
Martina Rossetti, Stefano Stanca, Leona Bokulic Panichi, et al.
Metabolic Brain Disease (2024) Vol. 40, Iss. 1
Closed Access | Times Cited: 1
Martina Rossetti, Stefano Stanca, Leona Bokulic Panichi, et al.
Metabolic Brain Disease (2024) Vol. 40, Iss. 1
Closed Access | Times Cited: 1
The Role of Neuroglia in the Development and Progression of Schizophrenia
Neha S. Rawani, Allen W. Chan, Kathryn G. Todd, et al.
Biomolecules (2024) Vol. 15, Iss. 1, pp. 10-10
Open Access | Times Cited: 1
Neha S. Rawani, Allen W. Chan, Kathryn G. Todd, et al.
Biomolecules (2024) Vol. 15, Iss. 1, pp. 10-10
Open Access | Times Cited: 1
Metabolic Side Effects from Antipsychotic Treatment with Clozapine Linked to Aryl Hydrocarbon Receptor (AhR) Activation
Karin Fehsel
Biomedicines (2024) Vol. 12, Iss. 10, pp. 2294-2294
Open Access
Karin Fehsel
Biomedicines (2024) Vol. 12, Iss. 10, pp. 2294-2294
Open Access
